Education
About Us
Working with TipRanks
Follow Us
IDT Australia Limited (AU:IDT)
:IDT
IDT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.08 - AU$0.15
Previous CloseN/A
Volume22.00K
Average Volume (3M)393.44K
Market Cap
AU$38.04M
Enterprise ValueAU$43.24M
Total Cash (Recent Filing)AU$9.06M
Total Debt (Recent Filing)AU$346.00K
Price to Earnings (P/E)―
Beta1.32
Next Earnings
Sep 02, 2025EPS EstimateN/A
Last Dividend Ex-Date
Apr 12, 2010Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding429,677,860
10 Day Avg. Volume357,812
30 Day Avg. Volume393,445
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.07
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
IDT Australia Limited News
PremiumCompany Announcements
IDT Australia Limited Announces Cessation of Performance Rights
PremiumCompany Announcements
IDT Australia Reports Strong H1FY25 Performance and Strategic Expansions
PremiumCompany Announcements
IDT Australia Sees Revenue Surge Despite Ongoing Losses
PremiumCompany Announcements
IDT Australia Sees Record Revenue Growth Amid Strategic ShiftPremiumCompany Announcements
IDT Australia Secures $20 Million Loan Facility for Expansion
PremiumCompany Announcements
IDT Australia Secures $20 Million Loan for Growth
PremiumCompany Announcements
IDT Australia Sees Strong Support at AGM
PremiumCompany Announcements
IDT Australia Stresses Investor Caution Amid Market Risks---
IDT FAQ
What was IDT Australia Limited’s price range in the past 12 months?
IDT Australia Limited lowest share price was AU$0.08 and its highest was AU$0.14 in the past 12 months.
What is IDT Australia Limited’s market cap?
IDT Australia Limited’s market cap is AU$38.04M.
When is IDT Australia Limited’s upcoming earnings report date?
IDT Australia Limited’s upcoming earnings report date is Sep 02, 2025 which is in 148 days.
How were IDT Australia Limited’s earnings last quarter?
IDT Australia Limited released its earnings results on Feb 18, 2025. The company reported -AU$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.008.
Is IDT Australia Limited overvalued?
According to Wall Street analysts IDT Australia Limited’s price is currently Overvalued.
Does IDT Australia Limited pay dividends?
IDT Australia Limited pays a Annually dividend of AU$0.009 which represents an annual dividend yield of N/A. See more information on IDT Australia Limited dividends here
What is IDT Australia Limited’s EPS estimate?
IDT Australia Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IDT Australia Limited have?
IDT Australia Limited has 429,677,860 shares outstanding.
What happened to IDT Australia Limited’s price movement after its last earnings report?
IDT Australia Limited reported an EPS of -AU$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -16.667%.
Which hedge fund is a major shareholder of IDT Australia Limited?
Currently, no hedge funds are holding shares in AU:IDT
---
IDT Australia Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:IDT Sentiment 70%
Sector Average 68%
Sector Average 68%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
16.45%
12-Months-Change
Fundamentals
Return on Equity
-19.31%
Trailing 12-Months
Asset Growth
30.67%
Trailing 12-Months
Company Description
IDT Australia Limited
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. It offers analytical method development, stability chambers, and chemistry and microbiology quality control laboratory services. The company also provides project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs, as well as pharmaceutical development services in various dosage forms. In addition, it offers medicinal cannabis products, as well as various contract manufacturing services. The company was founded in 1975 and is headquartered in Boronia, Australia.
---
Technical Analysis
CSL
―
Cynata Therapeutics Limited
―
Patrys Limited
―
Starpharma Holdings Limited
―
Recce Pharmaceuticals Ltd.
―
---